121 related articles for article (PubMed ID: 23357741)
21. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.
de Vegt F; Dekker JM; Jager A; Hienkens E; Kostense PJ; Stehouwer CD; Nijpels G; Bouter LM; Heine RJ
JAMA; 2001 Apr; 285(16):2109-13. PubMed ID: 11311100
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of serum testosterone for type 2 diabetes risk assessment in men.
Atlantis E; Fahey P; Martin S; O'Loughlin P; Taylor AW; Adams RJ; Shi Z; Wittert G
BMC Endocr Disord; 2016 May; 16(1):26. PubMed ID: 27230668
[TBL] [Abstract][Full Text] [Related]
23. Derivation and validation of diabetes risk score for urban Asian Indians.
Ramachandran A; Snehalatha C; Vijay V; Wareham NJ; Colagiuri S
Diabetes Res Clin Pract; 2005 Oct; 70(1):63-70. PubMed ID: 16126124
[TBL] [Abstract][Full Text] [Related]
24. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
[TBL] [Abstract][Full Text] [Related]
25. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
[TBL] [Abstract][Full Text] [Related]
26. Subjects with impaired fasting glucose: evolution in a period of 6 years.
Leiva E; Mujica V; Orrego R; Wehinger S; Soto A; Icaza G; Vásquez M; Díaz L; Andrews M; Arredondo M
J Diabetes Res; 2014; 2014():710370. PubMed ID: 25215305
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study.
Ursini F; Russo E; D'Angelo S; Arturi F; Hribal ML; D'Antona L; Bruno C; Tripepi G; Naty S; De Sarro G; Olivieri I; Grembiale RD
Medicine (Baltimore); 2016 Feb; 95(7):e2552. PubMed ID: 26886599
[TBL] [Abstract][Full Text] [Related]
28. Predictive factors of developing type 2 diabetes mellitus, Acute Myocardial Infarction and stroke in a cohort with Impaired Fasting Glucose in Singapore.
Chia DB; Wong LY; Liu DYK; Toh MPHS
Diabetes Res Clin Pract; 2017 Oct; 132():59-67. PubMed ID: 28783533
[TBL] [Abstract][Full Text] [Related]
29. Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism.
Ruchat SM; Vohl MC; Weisnagel SJ; Rankinen T; Bouchard C; Pérusse L
Ann Med; 2010 Apr; 42(3):196-206. PubMed ID: 20384434
[TBL] [Abstract][Full Text] [Related]
30. Validation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: combined results of the Inter99 and Botnia studies.
Lyssenko V; Jørgensen T; Gerwien RW; Hansen T; Rowe MW; McKenna MP; Kolberg J; Pedersen O; Borch-Johnsen K; Groop L
Diab Vasc Dis Res; 2012 Jan; 9(1):59-67. PubMed ID: 22058089
[TBL] [Abstract][Full Text] [Related]
31. Predicting the 20-year diabetes incidence rate.
Dankner R; Abdul-Ghani MA; Gerber Y; Chetrit A; Wainstein J; Raz I
Diabetes Metab Res Rev; 2007 Oct; 23(7):551-8. PubMed ID: 17315136
[TBL] [Abstract][Full Text] [Related]
32. Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk.
Sevilla-González MDR; Merino J; Moreno-Macias H; Rojas-Martínez R; Gómez-Velasco DV; Manning AK
Cardiovasc Diabetol; 2021 Feb; 20(1):56. PubMed ID: 33639941
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study.
Hellgren MI; Petzold M; Björkelund C; Wedel H; Jansson PA; Lindblad U
Diabet Med; 2012 Dec; 29(12):1501-5. PubMed ID: 22443428
[TBL] [Abstract][Full Text] [Related]
34. Progression rate of newly diagnosed impaired fasting glycemia to type 2 diabetes mellitus: a study using the National Healthcare Group Diabetes Registry in Singapore.
Ang YG; WU CX; Toh MP; Chia KS; Heng BH
J Diabetes; 2012 Jun; 4(2):159-63. PubMed ID: 22059651
[TBL] [Abstract][Full Text] [Related]
35. Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis).
Yeboah J; Bertoni AG; Herrington DM; Post WS; Burke GL
J Am Coll Cardiol; 2011 Jul; 58(2):140-6. PubMed ID: 21718910
[TBL] [Abstract][Full Text] [Related]
36. [Effect of menopausal status on onset of impaired fasting glucose and type 2 diabetes mellitus].
Wen JB; Yang S; Zhao XH; Chen YC; Zhao HL; Chen XT; Shen C
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):728-733. PubMed ID: 28763923
[No Abstract] [Full Text] [Related]
37. Six-year follow-up study on the association between white blood cell count and fasting blood glucose level in Chinese adults: A community-based health examination survey.
Zang X; Meng X; Wang Y; Jin X; Wu T; Liu X; Geng H; Xu W; Wang Y; Teng F; Qiu Q; Yang M; Liang J
Diabetes Metab Res Rev; 2019 May; 35(4):e3125. PubMed ID: 30614185
[TBL] [Abstract][Full Text] [Related]
38. Impaired fasting glucose and impaired glucose tolerance do not predict hypertension: a community cohort study.
Lee CJ; Lim NK; Kim HC; Ihm SH; Lee HY; Park HY; Park S
Am J Hypertens; 2015 Apr; 28(4):493-500. PubMed ID: 25267735
[TBL] [Abstract][Full Text] [Related]
39. Cumulative exposure to impaired fasting glucose and future risk of type 2 diabetes mellitus.
Kim MK; Han K; Koh ES; Hong OK; Baek KH; Song KH; Kwon HS
Diabetes Res Clin Pract; 2021 May; 175():108799. PubMed ID: 33845053
[TBL] [Abstract][Full Text] [Related]
40. Identifying glucose thresholds for incident diabetes by physiological analysis: a mathematical solution.
Ferrannini E; Manca ML
Am J Physiol Regul Integr Comp Physiol; 2015 Apr; 308(7):R590-6. PubMed ID: 25552659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
